Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study

BACKGROUND: Unwanted submental fat (SMF) may result in an unattractive chin profile and dissatisfaction with appearance. An approved and rigorously tested non-surgical method for SMF reduction is lacking. OBJECTIVE: To evaluate the efficacy and safety of ATX-101 for the pharmacological reduction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascher, B, Hoffmann, K, Walker, P, Lippert, S, Wollina, U, Havlickova, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263247/
https://www.ncbi.nlm.nih.gov/pubmed/24605812
http://dx.doi.org/10.1111/jdv.12377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263247/
https://www.ncbi.nlm.nih.gov/pubmed/24605812
http://dx.doi.org/10.1111/jdv.12377

Ejemplares similares